Paxlovid may not significantly benefit vaccinated seniors, study says |
|
| | | By Alice Park
Senior Correspondent |
|
|
|
| We’ve all become more adept at managing COVID-19, from recognizing its symptoms to testing ourselves and seeking out antiviral treatments like Paxlovid. But since the initial studies on that drug were done, one major thing has changed: Most people in the U.S. are now vaccinated. | So how effective is Paxlovid in vaccinated people who are also at high risk of severe COVID-19? Here’s what researchers recently learned. | | | | | | |  | Here Are Trump’s Major Moves on Reproductive Health Access | In his first month in office, Trump has taken several actions affecting reproductive healthcare access. |
| |
|
|  | Why Walking Isn't Enough When It Comes to Exercise | Walking is great, but it can only take you so far. |
| |
|
|  | 7 Things to Say When Someone Gaslights You | We asked experts what to say and why it works. |
| |
|
| If you were forwarded this and want to sign up to receive it daily, click here. Today's newsletter was written by Alice Park and edited by Angela Haupt. | | | | |
|
